tiprankstipranks
Advertisement
Advertisement

DE:VX1 Stock Latest News

Vertex Pharmaceuticals: Solid CF Franchise and Emerging Pipeline Support Buy Rating and Premium Valuation
RatingsVertex Pharmaceuticals: Solid CF Franchise and Emerging Pipeline Support Buy Rating and Premium Valuation
1d ago
VRTX
Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley
6d ago
VRTX
Vertex Pharmaceuticals price target raised to $543 from $541 at RBC Capital
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $543 from $541 at RBC Capital
9d ago
VRTX
Halozyme enters global global collaboration and license agreement with Vertex
PremiumThe Fly
Halozyme enters global global collaboration and license agreement with Vertex
9d ago
HALO
VRTX
Vertex announces U.S. FDA approval for label extensions of Alyftrek, Trikafta
PremiumThe Fly
Vertex announces U.S. FDA approval for label extensions of Alyftrek, Trikafta
15d ago
VRTX
Vertex Advances FDA Filing for IgA Nephropathy Therapy
PremiumCompany AnnouncementsVertex Advances FDA Filing for IgA Nephropathy Therapy
16d ago
8K
VRTX
Vertex Pharmaceuticals: Resilient CF Franchise and Advancing Pipeline Support Buy Rating Despite Label Headwinds
Premium
Ratings
Vertex Pharmaceuticals: Resilient CF Franchise and Advancing Pipeline Support Buy Rating Despite Label Headwinds
17d ago
VRTX
Maze Therapeutics share sell-off an ‘overreaction,’ says Raymond James
Premium
The Fly
Maze Therapeutics share sell-off an ‘overreaction,’ says Raymond James
22d ago
MAZE
VRTX
Leerink remains bullish on Maze, says Vertex comparison ‘apples to oranges’
PremiumThe Fly
Leerink remains bullish on Maze, says Vertex comparison ‘apples to oranges’
22d ago
MAZE
VRTX
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $550 from $515 at Wells Fargo
28d ago
AMGN
REGN
Amgen price target raised to $390 from $375 at Wells Fargo
PremiumThe Fly
Amgen price target raised to $390 from $375 at Wells Fargo
28d ago
AMGN
REGN
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
29d ago
CF
EXR
Maxim upgrades Vertex to Buy on diversification of revenue
PremiumThe FlyMaxim upgrades Vertex to Buy on diversification of revenue
29d ago
VRTX
Vertex Pharmaceuticals upgraded to Buy from Hold at Maxim
Premium
The Fly
Vertex Pharmaceuticals upgraded to Buy from Hold at Maxim
29d ago
VRTX
Insmed assumed with a Buy at Jefferies
Premium
The Fly
Insmed assumed with a Buy at Jefferies
1M ago
INSM
VRTX
Vertex Pharmaceuticals price target raised to $525 from $490 at Truist
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $525 from $490 at Truist
1M ago
VRTX
Vera Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research
PremiumThe Fly
Vera Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research
1M ago
VERA
VRTX
Early notable gainers among liquid option names on March 10th
PremiumThe Fly
Early notable gainers among liquid option names on March 10th
1M ago
MU
GLW
Video: Kohl’s slips after Q4 earnings report
PremiumThe Fly
Video: Kohl’s slips after Q4 earnings report
1M ago
HPE
KSS
Morning Movers: BioNTech sinks following departure of founders, Q4 results
PremiumThe FlyMorning Movers: BioNTech sinks following departure of founders, Q4 results
1M ago
BG
HPE
Vertex poses ‘no threat’ to Vera Therapeutics’ atacicept, says BofA
Premium
The Fly
Vertex poses ‘no threat’ to Vera Therapeutics’ atacicept, says BofA
1M ago
VERA
VRTX
Vertex Pharmaceuticals price target raised to $600 from $540 at Oppenheimer
Premium
The Fly
Vertex Pharmaceuticals price target raised to $600 from $540 at Oppenheimer
1M ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >